Pharmaceutical packaging is of paramount importance for protecting medications, ensuring patient safety, complying with regulations, providing essential information, supporting brand identity, and addressing environmental considerations. The role of pharmaceutical packaging in safeguarding the integrity and efficacy of medications underscores its significance in the pharmaceutical industry and its impact on public health and safety.

The pharmaceutical packaging in Asia Pacific market size is projected to grow by USD 4.0 billion from 2023 to 2029, registering a CAGR of 3.49 percent, according to the latest market data.

This comprehensive industry report provides market estimates and forecasts, accompanied by a detailed examination of the packaging type, material, end user, and country aspects. It delivers a quantitative analysis of the market, empowering stakeholders to leverage existing market opportunities. Furthermore, the report identifies key segments for potential opportunities and strategies, drawing insights from market trends and the approaches of leading competitors.

The global baby bottle market has been extensively analyzed by categorizing it according to various sub-segments in order to provide accurate forecasts of industry size and assess trends within specific areas.
The Asia Pacific market for pharmaceutical packaging can be segmented by packaging type: primary packaging (blister packs, bottles, vials, ampoules, others), secondary packaging, tertiary packaging. According to the research, the primary packaging segment had the largest share in the pharmaceutical packaging market in Asia Pacific.
Pharmaceutical packaging market is further segmented by material: glass, paper, plastics, others. In 2022, the paper segment made up the largest share of revenue generated by the pharmaceutical packaging market.
Based on end user, the pharmaceutical packaging market is segmented into: CMOs/CDMOs, pharmaceutical companies, others. Among these, the pharmaceutical companies segment was accounted for the highest revenue generator in 2022.
On the basis of country, the pharmaceutical packaging market also can be divided into: China, Japan, South Korea, India, Australia, Rest of Asia-Pacific. China captured the largest share of the market in 2022.

The report explores the recent developments and profiles of key vendors in the Pharmaceutical Packaging Market in Asia Pacific, including AGC Inc., AptarGroup, Inc., Becton, Dickinson and Company, Berry Global Group, Inc., Gerresheimer AG, Nipro Corporation, Schott AG, SGD S.A., Sharp Services, LLC, WestRock Company, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Why Choose This Report

Gain a reliable outlook of the pharmaceutical packaging market in Asia Pacific forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

Market Segments Covered in Asia Pacific Pharmaceutical Packaging Industry Analysis:
i.) Packaging type
– Primary packaging (blister packs, bottles, vials, ampoules, others)
– Secondary packaging
– Tertiary packaging

ii.) Material
– Glass
– Paper
– Plastics
– Others

iii.) End user
– CMOs/CDMOs
– Pharmaceutical companies
– Others

iv.) Country
– China
– Japan
– South Korea
– India
– Australia
– Rest of Asia-Pacific